A detailed history of Eventide Asset Management, LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 1,265,653 shares of CELC stock, worth $13.2 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
1,265,653
Previous 1,535,000 17.55%
Holding current value
$13.2 Million
Previous $22.9 Million 27.61%
% of portfolio
0.32%
Previous 0.4%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$12.0 - $16.35 $3.23 Million - $4.4 Million
-269,347 Reduced 17.55%
1,265,653 $16.6 Million
Q2 2024

Aug 13, 2024

BUY
$14.1 - $20.78 $2.04 Million - $3.01 Million
145,000 Added 10.43%
1,535,000 $25.1 Million
Q1 2024

May 15, 2024

BUY
$13.74 - $21.6 $19.1 Million - $30 Million
1,390,000 New
1,390,000 $30 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $156M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.